Weiwei Li
South China Agricultural University(CN)Hebei Medical University(CN)Fujian Medical University(CN)Binzhou Medical University(CN)Binzhou University(CN)Chinese Academy of Sciences(CN)Ruijin Hospital(CN)Soochow University(CN)Institute of Hydrobiology(CN)Jiaxing University(CN)Second Hospital of Hebei Medical University(CN)Shenzhen Maternity and Child Healthcare Hospital(CN)Shaoxing No.6 People's Hospital(CN)First Affiliated Hospital of Fujian Medical University(CN)Institute of Genetics and Developmental Biology(CN)Second Affiliated Hospital of Soochow University(CN)Dian Diagnostics (China)(CN)Ministry of Agriculture and Rural Affairs(CN)Beijing Tsinghua Chang Gung Hospital(CN)Shaoxing People's Hospital(CN)University of Chinese Academy of Sciences(CN)
Publications by Year
Research Areas
MicroRNA in disease regulation, Cancer-related molecular mechanisms research, Circular RNAs in diseases, Reconstructive Surgery and Microvascular Techniques, DNA Repair Mechanisms
Most-Cited Works
- → The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors(2010)435 cited
- → α7 Nicotinic Acetylcholine Receptors Mediate β-Amyloid Peptide-induced Tau Protein Phosphorylation(2003)184 cited
- → The Rho kinase inhibitor fasudil inhibits tumor progression in human and rat tumor models(2006)178 cited
- → CD147 promotes reprogramming of glucose metabolism and cell proliferation in HCC cells by inhibiting the p53-dependent signaling pathway(2014)153 cited
- → Heterogenic Loss of the Wild-Type BRCA Allele in Human Breast Tumorigenesis(2007)98 cited
- → Calmodulin kinase II is required for angiotensin II-mediated vascular smooth muscle hypertrophy(2009)78 cited